Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
18.60
+0.12 (0.65%)
Oct 28, 2025, 4:00 PM EDT - Market closed
Eton Pharmaceuticals Market Cap
Eton Pharmaceuticals has a market cap or net worth of $498.81 million as of October 29, 2025. Its market cap has increased by 141.33% in one year.
Market Cap
498.81M
Enterprise Value
504.12M
1-Year Change
141.33%
Ranking
Category
Stock Price
$18.60
Market Cap Chart
Since November 13, 2018, Eton Pharmaceuticals's market cap has increased from $105.74M to $498.81M, an increase of 371.73%. That is a compound annual growth rate of 24.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 498.81M | 40.60% |
| Dec 31, 2024 | 354.78M | 215.68% |
| Dec 29, 2023 | 112.38M | 57.54% |
| Dec 30, 2022 | 71.34M | -32.42% |
| Dec 31, 2021 | 105.56M | -46.38% |
| Dec 31, 2020 | 196.86M | 53.54% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 13, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.04B |
| Johnson & Johnson | 457.77B |
| AbbVie | 402.76B |
| UnitedHealth Group | 328.31B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 220.78B |